|
GB202019449D0
|
|
Macrolide derivatives and pharmaceutical compositions thereof
|
|
GB202010464D0
|
|
Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
|
|
GB202001421D0
|
|
Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
|
|
GB202001420D0
|
|
Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
|
|
GB201918276D0
|
|
Macrolide derivatives and pharmaceutical compositions thereof
|
|
GB201911868D0
|
|
Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
|
|
EP3782997A1
|
|
Fused pyrimidine compounds and pharmaceutical compositions thereof for the treatment of fibrotic diseases
|
|
TW202011995A
|
|
High concentration liquid antibody formulations
|
|
KR20210022055A
|
|
New compounds for the treatment of diseases and pharmaceutical compositions thereof
|
|
GB201907558D0
|
|
Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
|
|
GB201907616D0
|
|
Novel compounds and pharmaceutical compositons thereof for the treatment of diseases
|
|
GB201907547D0
|
|
Novel compounds and pharmaceutical compositions thereof for the treatment of hepatitis B
|
|
GB201905711D0
|
|
Novel compounds and pharmaceutical compositions thereof for the treatment of kidney diseases
|
|
GB201905536D0
|
|
Novel compounds and pharmaceutical compositions thereof for the treatment of metabolic disorders
|
|
GB201904373D0
|
|
Novel compounds and pharamaceutical compositions thereof for the treatment of inflammatory disorders
|
|
GB201904374D0
|
|
Novel compunds and pharmaceutical composistions thereof for the treatment of inflammatory disorders
|
|
GB201904375D0
|
|
Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
|
|
GB201902490D0
|
|
Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
|
|
GB201902011D0
|
|
Macrolide derivatives and pharmaceutical compositions thereof
|
|
KR20200096571A
|
|
New compounds for the treatment of diseases and pharmaceutical compositions thereof
|
